TGODF - The Green Organic Dutchman Holdings Ltd.

Other OTC - Other OTC Delayed Price. Currency in USD
3.0007
+0.0007 (+0.02%)
As of 11:40AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close3.0000
Open3.0700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.9800 - 3.1200
52 Week Range1.6070 - 7.8940
Volume312,716
Avg. Volume1,156,701
Market Cap827.176M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1270
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • TGOD Secures Supply Agreement with Alberta
    CNW Group5 hours ago

    TGOD Secures Supply Agreement with Alberta

    TGOD Secures Supply Agreement with Alberta

  • The Green Organic Dutchman (TGODF) Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast
    SmarterAnalyst4 days ago

    The Green Organic Dutchman (TGODF) Stock — Not Sinking Exactly, But Not Sailing Anywhere Fast

    Canadian cannabis company The Green Organic Dutchman (TGODF) reported fiscal Q1 2019 earnings late Tuesday. It's Monday now and, if this is the first you've heard of the news -- don't be surprised. "TGOD" didn't exactly make a lot of headlines with its earnings news, and investors mostly slept through the report.TGOD stock was up a mere 1.4% on Wednesday after the report ... and flatlined on Thursday and Friday -- no change at all.Why so little fanfare? After all, didn't TGOD grow its sales 28% year over year in Q1?Well, yes, it did. However, even that strong growth rate still left TGOD selling little more than a corporate-scale dime bag of product for the quarter -- $2.4 million, to be precise. And TGOD didn't even make a profit on the transaction. To the contrary, TGOD reported a $14.1 million net loss in Q1, "as it continues its preparation for commercial production and entry into the recreational market later this year," said management.So how did Wall Street analysts react to the report? Well, let's see here. Seaport Global's Brett Hundley, which has taken a keen interest in Canadian pot stocks of late, opined that TDOG's miniscule sales were at least "in line with expectations for Q1," while the company's "EBITDA loss ... was slightly worse than anticipated.""No matter," though, said Hundley (his words, not ours). Because in the analyst's view, "reported results are largely immaterial and much of the forward focus for this company remains on the potential for forward commercialization and consumer adoption."Hundley, it seems, is viewing TGOD not so much as a business (which is, you know, supposed to make sales and earn profit) as his is seeing the company as a story stock -- which only really needs to tell a compelling tale to attract investor interest. And in this regard, the analyst sees TGOD as succeeding: * TGOD "remains on track for its build-out of facilities." (Translation: It hasn't built a lot of facilities yet). * And TGOD "intends to enter the Canadian adult-use market in ON and BC during Q4, before expanding nationally in 2020." (Translation: It hasn't yet managed to break into the Canadian adult-use market -- nationally or otherwise). * Perhaps most tellingly of all, Hundley notes that of the $2.4 million in sales TGOD did make during the quarter, these sales were "primarily derived from the company's HemPoland subsidiary, consistent with Q4."And if you recall, TGOD bought HemPoland last August, so most of the sales the company made... came from another company that it bought.If all of the above has you wondering what it is, exactly, that Hundley sees in TGOD that merits a "buy" rating (and the analyst does indeed recommend buying TGOD stock), well, you're not alone. A lot of investors yesterday and the day before seem to have wondered the same thing. That being said, there is one small factor to consider that may shed a ray of hope for TGOD bulls.To wit, TGOD operates in the high-margin "organic" segment of the marijuana market, and Hundley says it's been successful selling organic marijuana flower for as much as $12 a gram (and other pot companies have gotten even better prices). Considering that TGOD eventually hopes to produce organic marijuana for as little as $1 a gram, that seems to offer a lot of room for robust profit margins.Whether those margins will ever be robust enough to justify TGOD's current valuation of 247 times sales, of course, remains to be seen.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click here. Read more on TGOD: The Green Organic Dutchman Offers the Best Value for Investors More recent articles from Smarter Analyst: * GW Pharmaceuticals (GWPH) Stock Could Run Much Higher Over Time * Trade Tensions Bring Micron (MU) Stock Down, But Cascend Remains Bullish * Susquehanna Remains Bullish on Qualcomm (QCOM) Stock as the Roller Coaster Ride Continues * Trump's Trade War Hits U.S. Tech Companies from California to North Carolina

  • Green Organic Dutchman’s Losses Narrow as Revenue Rises in Q1
    Market Realist9 days ago

    Green Organic Dutchman’s Losses Narrow as Revenue Rises in Q1

    Green Organic Dutchman's Losses Narrow as Revenue Rises in Q1TGOD Q1 earningsGreen Organic Dutchman Holdings (TGOD) (TGODF) reported its first-quarter earnings yesterday after the markets closed. It reported revenues of $2.4 million in the quarter,

  • The Green Organic Dutchman Reports Q1 Fiscal 2019 Results
    PR Newswire10 days ago

    The Green Organic Dutchman Reports Q1 Fiscal 2019 Results

    TORONTO, May 14, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three months ended March 31, 2019. Is on-track with construction at Hamilton and Valleyfield sites, with investment amounting to $46.9 million in the first quarter of 2019, an increase of $7.4 million compared to $39.5 million incurred in the fourth quarter 2018. Launched its Grower's Circle on March 25th, 2019, commencing direct to patient medical sales in Canada with products from its existing Hamilton facility.

  • How TGOD’s Valuation Compares with Its Peers
    Market Realist10 days ago

    How TGOD’s Valuation Compares with Its Peers

    TGOD Obtains Approval for Cultivation at Its Hamilton Building(Continued from Prior Part)Valuation multipleThe surge in The Green Organic Dutchman Holdings’ (TGOD)(TGODF) stock price since the beginning of 2019 has raised its valuation multiple.

  • TGOD Obtains Approval for Cultivation at Its Hamilton Building
    Market Realist10 days ago

    TGOD Obtains Approval for Cultivation at Its Hamilton Building

    TGOD Obtains Approval for Cultivation at Its Hamilton BuildingThe announcementToday, The Green Organic Dutchman Holdings (TGOD)(TGODF) announced that it received approval from Health Canada for cultivation at its facility in Hamilton, Ontario. The

  • TGOD Receives Health Canada Approval to Start Cultivation Operations at New Hamilton Building
    PR Newswire10 days ago

    TGOD Receives Health Canada Approval to Start Cultivation Operations at New Hamilton Building

    TORONTO, May 14, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. "This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence," commented Brian Athaide, CEO of TGOD. "We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale.

  • TGOD Enters German CBD Market, Inks Distribution Agreement with Mediakos
    PR Newswire11 days ago

    TGOD Enters German CBD Market, Inks Distribution Agreement with Mediakos

    TORONTO, May 13, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (TGOD) (TGOD.TO) (TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has entered into an agreement with Mediakos UG haftungsbeschraenkt (Mediakos) to be the exclusive distributor of CannabiGold, its premium hemp CBD brand, for the German pharmacy market. Mediakos UG spun out of Aponeo.de, a leading German online pharmacy, and is managed by a team of seasoned industry executives with demonstrated expertise in marketing and distribution of health and wellness products. It currently distributes a broad portfolio of products to a network of more than 15,000 pharmacies and can capitalize on over 10 million customers.

  • 5 under-the-radar marijuana stocks that could pay off
    MarketWatch14 days ago

    5 under-the-radar marijuana stocks that could pay off

    The first stories trumpeting the business opportunities in marijuana started popping up around 2016, as ballot initiatives that year legalized recreational marijuana in California, Nevada, Maine and Massachusetts. Most notably, $4 billion marijuana leader Cronos Group (CRON)(CA:CRON)  has plunged more than 40% from its recent highs. Yes, there are also a bunch of microcap marijuana stocks out there that are incredibly risky.

  • TGOD Secures Supply Agreement with British Columbia
    CNW Group15 days ago

    TGOD Secures Supply Agreement with British Columbia

    TGOD Secures Supply Agreement with British Columbia

  • The Green Organic Dutchman Enters US Market Through Cornerstone Investment in Califormulations LLC
    CNW Group16 days ago

    The Green Organic Dutchman Enters US Market Through Cornerstone Investment in Califormulations LLC

    TORONTO , May 8, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce the Company's strategic investment into the US beverage space as a co-founding investor and strategic partner in the newly formed Califormulations LLC ("Califormulations"). Califormulations will operate out of Columbus, Georgia serving global branded companies with concept-to-shelf beverage commercialization support including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination. TGOD will work with Califormulations to expedite the US launch of TGOD branded organic hemp-based CBD beverages, as local laws and regulations permit.

  • TipRanks17 days ago

    These 2 Cannabis Stocks Will be the Global Leaders In 5 Years, Says Analyst

    Jefferies analyst Owen Bennett has just released a very valuable report concerning cannabis stocks. What’s interesting is that he distinguishes between the stocks that will be dominating the market in five years’ time, and the stocks where investors can find the best value right now. “On a five-year view we continue to believe that Canopy and Aurora will be the global leaders,” Bennett told investors on Friday. However, on a 12 months basis, the analyst believes two smaller Canadian producers, The Green Organic Dutchman Holdings and CannTrust Holdings, currently offer the best value for investors. Let’s take a closer look at how these four stocks measure up now: Global Leaders Canopy Growth Corp (NYSE:CGC) (TSE:WEED)Despite his confidence in Canopy’s leadership position, Bennett nonetheless has a ‘Hold’ rating on the world’s largest cannabis company. He ascribes this rating to CGC’s current high valuation. However, if it comes to picking between Canopy and Aurora, the analyst is clear which stock he prefers:“Since initiation, we have argued that Canopy, along with Aurora, is best placed to dominate on a global basis in the years ahead. The Acreage deal further supports this view, giving Canopy a route to participation in the world's largest market, and, for us, now gives Canopy a notable advantage over Aurora in terms of its long term outlook” writes Bennett. Canopy recently announced a $3.4 billion acquisition of New York-based marijuana stock Acreage Holdings. The deal would go through as soon as cannabis has been fully legalized in the US. And with this in mind, the analyst ramps up his price target from C$64 to $C77 (17% upside potential). On the back of this deal, Canopy is now the only name in the analyst’s coverage which captures US (psychoactive) cannabis exposure in the price target.He continues: “Despite Canopy's strong global positioning, and the additional value creation to potentially come via the Acreage deal, we think this is appropriately reflected in the current price, the stock up >20% since the Acreage news broke (and 80% YTD). As such we maintain our Hold rating.”However it is worth noting that the Acreage deal, although agreed by the two companies, still requires shareholder consent. And activist investor Marcato Capital is fighting the proposed takeover, arguing that the company is worth much more than the agreed $3.4 billion. Marcato owns a 2.7% stake in Acreage. “We believe Acreage’s strategic value, as one of the few multi-state operators of scale in the U.S., with leading positions in the most valuable markets merits a significant premium to any stand-alone cash-flow derived valuation,” Marcato Capital wrote in an open letter to the board. “Furthermore, we believe enterprise values of cannabis companies will skyrocket upon the relaxation of current Federal restrictions.“Accordingly, Marcato believes it is highly imprudent for Acreage to sell itself today at the proposed valuation, with so much unlocked growth and value embedded in the company.” Shareholders will vote on the deal on June 19. Overall, the marijuana grower boasts a cautiously optimistic Moderate Buy analyst consensus. That’s with an average analyst price target of $60 (22% upside potential). We can also see that under the Canadian ticker, the average analyst share price works out at C$76.88. See what other Top Analysts are saying about CGC. Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB)Bennett has a more bullish Buy rating on Canadian cannabis producer Aurora. “Despite a recent good run (up 75% YTD and 29% since late February), we still believe Aurora's current valuation looks compelling relative to true global peers” explains Bennett. “We believe Aurora, along with Canopy, is best placed to dominate globally in the years ahead, yet the story is less appreciated. With infrastructure in place to strongly accelerate near-term Canadian sales as derivative products come on line, and US optionality to become more visible, we see further upside on a 12-month view. Shareholder dilution has been a risk in the past but we'd like to think this will now be more limited” he writes. Indeed, Bennett also boosted his Aurora price target from C$12 to C$14 (17% upside potential). Support for the move comes from multiple directions, including the recent $175 million transaction for premium cannabis producer Whistler, securing the maximum numbers of lots from the German domestic cultivation tender process, and appointing prominent activist consumer goods investor Nelson Peltz as a strategic advisor. Overall, we can see from TipRanks that Aurora also scores a ‘Moderate Buy’ consensus from the Street. That comes with an average analyst price target of C$13.80 (15% upside potential). See what other Top Analysts are saying about ACB. Best Value Now let’s move from two of the market’s biggest players to two smaller cannabis stocks that could make for savvy short-term investing opportunities. As Bennett writes: “We continue to see very good value at CannTrust and TGOD”: Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF)Green Organic is positioning itself to be the dominant player in the very attractive organic segment. Through its subsidiaries, the company produces farm grown and organic cannabis for medical use worldwide. Although a relatively new player, with an IPO in May 2018, the company has put in place all the tools to succeed.“We remain bullish on TGOD and continue to believe it is set up well to succeed” writes Bennett. “If you had to write a business plan entering the cannabis space late as they have done, then TGOD's approach would tick many of the boxes.” Namely: 1) hiring a management team with over 125 years of consumer goods experience; 2) operating in a relatively uncluttered segment (organic) that can command higher price points; and 3) access to robust capacity (enough to support the organic segment).Plus TGOD has also invested ahead in strong derivative infrastructure (i.e. announcing construction of a beverage focused division in June 2018); and invested internationally, for example with the acquisition of HemPoland in the hemp-based CBD space (distribution across 700 locations and 13 countries).However given that it only started shipping at the end of 1Q19, TGOD needs to execute into the rest of the year. “With potential issues with its Hamilton facility now resolved, we see no reason to believe that it won't. If it does then we see strong upside from here.” But- word of warning- this is a stock for the brave. Because if TGDO doesn’t pull through with strong upward momentum on sales across the quarters a sharp selloff is likely.Nonetheless Bennett is feeling confident. He has just increased his price target to C$6.50 from C$6.10 previously. Given the stock is currently trading at just $4.34 this suggests shares can surge by 50% in the coming months. Encouragingly, the Street echoes this optimistic sentiment. TGOD scores a Strong Buy Street consensus with an average analyst price target of C$7.18.See what other Top Analysts are saying about TGOD. CannTrust Holdings Inc (NYSE:CTST) (TSE:TRST) If you haven’t heard of CannTrust Holdings before, listen up. This is a pharmaceutical company that develops and produces medical cannabis for healthcare sectors in Canada. “We think [CannTrust] can be up there with the top global players, yet its multiple is a fraction of global peers” enthuses the Jefferies analyst. He has a C$13 price target on TRST stock (62% upside potential). He believes the company is a very smart, consistent operator with an excellent outlook. “It is one of the strongest medical businesses in Canada, has been performing very well in early rec, is positioned well to capitalise in derivatives (as well as pet care), and has made some shrewd moves internationally (Pharma partnership, European regional operations, US optionality)” explains the analyst. Yet despite the attractive outlook, recent performance has been notably poor (down 30% since Q4 results), with the market reacting to the soft gross margin and negative EBITDA in 4Q. According to Bennett, this is unfair, as management has simply decided to invest for long-term gain rather than short-term profitability by, for example, securing a low cost supply of cannabis for extraction into derivative products and and list on the NYSE. Moreover, in pre-releasing 1Q expectations recently the company moved to reassure investors when it said gross profit margins would return to between 42%-46% (from 35%).Bottom line: “If CannTrust delivers as we expect it to then its valuation looks very appealing at current levels.” This is reflected by the stock’s Moderate Buy analyst consensus and robust average analyst price target. On the Toronto exchange the C$14 price target suggests 75% upside potential; on NYSE the $12.38 figure is 107% above current price levels.See what other Top Analysts are saying about CTST. Enjoy Research Reports on the Stocks in this Article:Aurora Cannabis Inc (ACB) Research ReportCanopy Growth Corp (CGC) Research ReportCannTrust Holdings Inc (CTST) Research ReportGreen Organic Dutchman Holdings Ltd (TGOD) Research Report

  • CNW Group17 days ago

    The Green Organic Dutchman Holdings Ltd. to Release First Quarter 2019 Earnings Results After Market Close on May 14, 2019

    The Green Organic Dutchman Holdings Ltd. to Release First Quarter 2019 Earnings Results After Market Close on May 14, 2019

  • TGOD Settlement with Hamilton City Council for Cannabis Greenhouse Signed and Approved
    PR Newswire21 days ago

    TGOD Settlement with Hamilton City Council for Cannabis Greenhouse Signed and Approved

    HAMILTON, ON, May 3, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to confirm that the Hamilton City Council and the Company have finalized and signed a settlement offer, and that the Local Planning Appeal Tribunal approved the settlement at a meeting on May 2, 2019. The facilities in Ancaster, Ontario will be capable of growing 17,500 kgs of premium certified organic cannabis annually. "This completes this chapter of our journey," said Brian Athaide, CEO of TGOD.

  • CNW Group23 days ago

    The Green Organic Dutchman and Epican Receive Second Retail Licence from the CLA, Announce Opening of Second Retail Dispensary in Jamaica

    MONTEGO BAY, Jamaica , May 1, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TGOD.TO) (TGODF) is pleased to announce, in conjunction with Epican Medicinals ("Epican"), the opening of its second legal cannabis retail store in Jamaica . Located on Montego Bay's "Hip Strip", the flagship location will open for business on May 4, 2019 . Montego Bay is a popular tourist destination and Jamaica's second largest city.

  • CNW Group24 days ago

    TGOD's Extraction Processing Provider Receives Organic Certification

    TORONTO , April 30, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TGOD.TO) (TGODF) is pleased to announce that its Kelowna -based extraction processing services provider, Valens GroWorks Corp. ("Valens"), has obtained its organic certification from Pro-Cert Organic Systems Ltd. "TGOD has been committed to organic since day one. Working with service providers who embrace organic as much as we do is paramount.  I want to congratulate the team at Valens for obtaining their organic certification," commented Brian Athaide , CEO of TGOD.

  • Say Hello to the Marijuana Industry's Secret Weapon
    Motley Fool24 days ago

    Say Hello to the Marijuana Industry's Secret Weapon

    Women are set to reshape the cannabis industry as both consumers and corporate leaders.

  • PR Newswire28 days ago

    TGOD's European Acquisition HemPoland Receives Organic Certification

    TORONTO, April 26, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that its wholly owned subsidiary, HemPoland, has received organic certification from EKOGWARANCJA PTRE. This organic certification is provided by the Polish Center for Accreditation on authority from the Minister of Agriculture and Rural Development. HemPoland's facilities, production processes and product offerings are now certified organic.